Orphan designation: Unesbulin Treatment of soft tissue sarcoma, 10/12/2021 Withdrawn
Orphan designation: Unesbulin Treatment of soft tissue sarcoma, 10/12/2021 Withdrawn
Orphan designation: Unesbulin Treatment of soft tissue sarcoma, 10/12/2021 Withdrawn
Orphan designation: Lactobacillus plantarum Treatment of amyotrophic lateral sclerosis, 16/12/2019 Withdrawn
Orphan designation: Alrefimotide acetate,riletamotide acetate,tapderimotide acetate Treatment of mesothelioma, 21/03/2024 Withdrawn
Orphan designation: Glofitamab Treatment of diffuse large B-cell lymphoma, 15/10/2021 Withdrawn
Human medicines European public assessment report (EPAR): Kentera (previously Oxybutynin Nicobrand), oxybutynin, Date of authorisation: 15/06/2004, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Azilect, rasagiline, Date of authorisation: 21/02/2005, Revision: 24, Status: Authorised
Agenda of the CVMP meeting 8-10 April 2025
Veterinary medicines safety day: How to report adverse events - simple guide
Veterinary medicines safety day: Adverse event reporting in the EU - presentation
Veterinary medicines safety day: Social media infocards